Doxorubicin - NDC Database (Page 2)
0069-4033 Mar 05, 2013
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
0069-4034 Mar 05, 2013
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
0069-4037 Mar 17, 2014
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
0069-4205 Nov 11, 2024
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
0069-5629 Mar 31, 2025
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
0143-9084 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9085 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9086 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9087 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9088 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9089 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9090 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9091 May 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
0143-9092 Jan 19, 2018
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
0143-9093 Jan 19, 2018
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
0338-9581 Dec 19, 2023
Doxorubicin Hydrochloride, Liposomal, Liposomal 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
Doxorubicin Hydrochloride, Liposomal, Liposomal 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
0409-0124 Apr 18, 2016
Doxorubicin Hydrochloride 2 mg/ml Intra-arterial; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
Doxorubicin Hydrochloride 2 mg/ml Intra-arterial; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0574-0930 Oct 25, 2021
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Suspension, Liposomal by Padagis Us LLC
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Suspension, Liposomal by Padagis Us LLC
0574-0931 Oct 25, 2021
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Suspension, Liposomal by Padagis Us LLC
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Suspension, Liposomal by Padagis Us LLC
0703-5040 Sep 01, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.